Contemporary Life Expectancy Following Transfemoral Transcatheter Aortic Valve Replacement—Data From a National Registry Perspective
Lifespan following successful TAVR has markedly improved over the past decade across age groups. Notably, patients younger than 80 years, at the time of TAVR exhibit an estimated survival exceeding 10 years. These findings should be integrated into Heart Team decision-making for optimal lifelong management of AS.
Authors
- Lior Zornitzki (ORCID: https://orcid.org/0000-0003-3245-2653)
- Gabby Elbaz‐Greener (ORCID: https://orcid.org/0000-0003-1922-9174)
- Yan Topilsky (ORCID: https://orcid.org/0000-0002-2269-802X)
- Arie Steinvil (ORCID: https://orcid.org/0000-0002-6070-4187)
- Ran Kornowski (ORCID: https://orcid.org/0000-0002-7708-8253)
- Ophir Freund (ORCID: https://orcid.org/0000-0002-7272-5284)
- Inbal Greenberg (ORCID: https://orcid.org/0000-0003-3972-7146)
- Jeremy Ben‐Shoshan (ORCID: https://orcid.org/0000-0002-0838-4358)
- Maayan Konigstein (ORCID: https://orcid.org/0000-0002-9398-471X)
- Danny Dvir
- Shir Frydman (ORCID: https://orcid.org/0000-0002-8882-9109)
- Israel M. Barbash (ORCID: https://orcid.org/0000-0002-7416-5989)
- Shmuel Banai (ORCID: https://orcid.org/0000-0002-3299-2839)
- Ariel Finkelstein
- Amir Halkin
Institutions
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Hadassah Medical Center (IL)
- Rabin Medical Center (IL)
- Shaare Zedek Medical Center (IL)
Publication Details
- Journal
- Structural Heart
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.shj.2025.100780
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00